ACM
NBP

AIHC Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

AIHC Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Buy
2,878,033
+615,100
+27% +$1.25M 5.38% 3
2026
Q1 		$5.57M Buy
2,262,933
+1,848,954
+447% +$6.19M 4.65% 3
2025
Q4 		$1.65M Buy
+413,979
New +$1.83M 1.54% 5

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AIHC Capital Management's NBP Position: Q2 2026 in Review

AIHC Capital Management increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 27% in Q2 2026, buying an estimated $1.25M and bringing the position to 2,878,033 shares worth $5.61M. The position accounts for 5.38% of the portfolio, ranked #3.

AIHC Capital Management first reported a position in NBP in Q4 2025 and has held it in 3 quarters since. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • AIHC Capital Management held 2,878,033 shares of NovaBridge Biosciences American Depositary Shares worth $5.61M as of Q2 2026.
  • AIHC Capital Management bought 615,100 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $1.25M.
  • NovaBridge Biosciences American Depositary Shares made up 5.38% of AIHC Capital Management's portfolio in Q2 2026, its #3 holding.
  • AIHC Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and has held it in 3 quarters since.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on AIHC Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.